Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle
about
The cytosolic carboxypeptidases CCP2 and CCP3 catalyze posttranslational removal of acidic amino acidsPutative biomarkers and targets of estrogen receptor negative human breast cancerExtracellular and Intracellular Signaling for Neuronal PolarityAnti-migratory effect of vinflunine in endothelial and glioblastoma cells is associated with changes in EB1 C-terminal detyrosinated/tyrosinated statusHigh-resolution structure of the M14-type cytosolic carboxypeptidase fromBurkholderia cenocepaciarefined exploitingPDB_REDOstrategiesHighly expressed genes in human high grade gliomas: immunohistochemical analysis of data from the human protein atlasClinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth.Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.Reverse differentiation as a gene filtering tool in genome expression profiling of adipogenesis for fat marker gene selection and their analysis.Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumorsAnalysis of tubulin alpha-1A/1B C-terminal tail post-translational poly-glutamylation reveals novel modification sites.Secretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein.Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.Cytosolic carboxypeptidase 5 removes α- and γ-linked glutamates from tubulin.Zebrafish cytosolic carboxypeptidases 1 and 5 are essential for embryonic development.Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.Molecular Pathways: New Signaling Considerations When Targeting Cytoskeletal Balance to Reduce Tumor Growth.Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibitionBone Microenvironment Changes in Latexin Expression Promote Chemoresistance.Zinc and zinc-containing biomolecules in childhood brain tumors.A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer.Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN.Computing molecular signatures as optima of a bi-objective function: method and application to prediction in oncogenomics.C-terminomics screen for natural substrates of cytosolic carboxypeptidase 1 reveals processing of acidic protein C termini.Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.
P2860
Q24301782-F41555C1-7A6E-42A8-94BC-D6F17B6FF147Q27003285-804CAFFF-2AAB-49DD-AF52-B19A3FB9E82BQ27005889-78060B7F-08ED-4DA5-8211-45B655C21FECQ27316401-90FB93DC-105F-4DFF-AD73-E37C1FB00A19Q27681751-7FBA99B7-8B3E-47BD-B2C4-2666BD575B3EQ30834672-661747B6-D010-4C34-9918-C278A9F7D300Q33800383-A3258113-8961-4E67-B02C-EDAE5AD6EC6BQ34083586-733E4814-0437-4C7B-B9EF-7AF109D4F3C3Q34086015-8CEB20D2-79FB-4D37-92E3-7FD8D4902438Q34427804-98409A24-2401-48E3-A75F-B74F9500B607Q34903773-9DF30E93-C080-4F47-85B3-5307A71B1D8DQ35257755-076EBB8E-DB52-4E7F-AC8C-8442ECB7ECCEQ35798534-48FAADD2-D2A0-41ED-845A-06A83618B2E9Q36197438-5DAA0A10-4648-411F-973D-54A9701FC092Q36775218-ABBEA96E-2D2E-41C7-9FD7-1C39BF781362Q37234065-3AE9F510-E962-4DDD-B694-39A15FAFE503Q37234070-5B57545E-4D0E-4BC5-A435-A1FCCB50BC54Q37536796-AE8F7893-A605-4A19-BE5D-DF8DE43B935BQ37691175-C38738C4-054D-4057-B674-64DAE10A63D4Q38606432-EA769386-EFCE-4B50-9FFA-0607CFD92DF5Q38662522-DCB9EB35-FED8-43DD-884B-52A51C6B6DCDQ38721352-6EDE40E2-5556-48F4-81F8-1FF8F4B48FF7Q38957110-D8A412D3-9D11-4F87-8041-2C37C594642EQ39302186-D90A36B5-DB28-45B9-A463-F7D3E7FC0D72Q39351158-A5B60C49-7BCC-4466-BAF3-83B94B11688BQ40289727-9FCB1C92-0CA6-453C-BE1B-E746B5B5D4ABQ40521338-64F78DD0-3ED0-4F09-92CB-2CF448B2D487Q43097822-1EBB86BC-A130-42F8-88BC-4C370836EDD1Q47110757-93B346DE-B15F-48B4-AF69-C790515DF04B
P2860
Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@ast
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@en
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@nl
type
label
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@ast
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@en
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@nl
prefLabel
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@ast
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@en
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@nl
P2093
P2860
P1433
P1476
Tumor suppressor RARRES1 inter ...... e α-tubulin tyrosination cycle
@en
P2093
Deepak Kumar
Michael D Hall
Sivanesan Dakshanamurthy
Stephen W Byers
You Me Sung
Ziad J Sahab
P2860
P304
P356
10.1158/0008-5472.CAN-10-2294
P407
P577
2011-02-08T00:00:00Z